Miranda E. Pitt

719 total citations
15 papers, 277 citations indexed

About

Miranda E. Pitt is a scholar working on Molecular Biology, Infectious Diseases and Epidemiology. According to data from OpenAlex, Miranda E. Pitt has authored 15 papers receiving a total of 277 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 6 papers in Infectious Diseases and 6 papers in Epidemiology. Recurrent topics in Miranda E. Pitt's work include Antibiotic Resistance in Bacteria (5 papers), Tuberculosis Research and Epidemiology (4 papers) and Antibiotics Pharmacokinetics and Efficacy (3 papers). Miranda E. Pitt is often cited by papers focused on Antibiotic Resistance in Bacteria (5 papers), Tuberculosis Research and Epidemiology (4 papers) and Antibiotics Pharmacokinetics and Efficacy (3 papers). Miranda E. Pitt collaborates with scholars based in Australia, China and United Kingdom. Miranda E. Pitt's co-authors include Lachlan Coin, Mark A. T. Blaskovich, Matthew A. Cooper, Alysha G. Elliott, Minh Duc Cao, Devika Ganesamoorthy, Mark S. Butler, Wanida Phetsang, Geraldine Kaeslin and Ruby Pelingon and has published in prestigious journals such as PLoS ONE, Frontiers in Immunology and Cell Reports.

In The Last Decade

Miranda E. Pitt

14 papers receiving 274 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Miranda E. Pitt Australia 11 122 93 46 34 31 15 277
Michael P. Motley United States 8 145 1.2× 112 1.2× 57 1.2× 27 0.8× 52 1.7× 10 361
Jean–Marc Juteau United States 9 131 1.1× 83 0.9× 81 1.8× 21 0.6× 20 0.6× 14 428
Sebastian Dintner Germany 11 196 1.6× 76 0.8× 83 1.8× 23 0.7× 67 2.2× 29 448
Brittany A. Fleming United States 7 124 1.0× 60 0.6× 43 0.9× 26 0.8× 13 0.4× 8 276
Mya Mya Aye Myanmar 6 91 0.7× 165 1.8× 70 1.5× 16 0.5× 17 0.5× 14 324
Coloma Costas Spain 11 165 1.4× 154 1.7× 52 1.1× 35 1.0× 34 1.1× 12 367
Christopher Connor United Kingdom 8 107 0.9× 191 2.1× 47 1.0× 29 0.9× 38 1.2× 15 384
Marius Surleac Romania 11 180 1.5× 113 1.2× 66 1.4× 13 0.4× 17 0.5× 30 400
Kamel Ben‐Mahrez Tunisia 11 167 1.4× 140 1.5× 8 0.2× 19 0.6× 23 0.7× 34 356
Katarzyna Mickiewicz United Kingdom 7 170 1.4× 67 0.7× 34 0.7× 27 0.8× 72 2.3× 12 353

Countries citing papers authored by Miranda E. Pitt

Since Specialization
Citations

This map shows the geographic impact of Miranda E. Pitt's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Miranda E. Pitt with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Miranda E. Pitt more than expected).

Fields of papers citing papers by Miranda E. Pitt

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Miranda E. Pitt. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Miranda E. Pitt. The network helps show where Miranda E. Pitt may publish in the future.

Co-authorship network of co-authors of Miranda E. Pitt

This figure shows the co-authorship network connecting the top 25 collaborators of Miranda E. Pitt. A scholar is included among the top collaborators of Miranda E. Pitt based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Miranda E. Pitt. Miranda E. Pitt is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Chowdhury, Piklu Roy, Ian Gassiep, Kay A. Ramsay, et al.. (2025). Co-isolation of genetically distinct Burkholderia pseudomallei strains from a single patient in North Queensland. PLoS ONE. 20(12). e0338333–e0338333.
2.
Guo, Xudong, Heyun Sun, Yue Bi, et al.. (2024). MERITS: a web-based integrated Mycobacterial PE/PPE protein database. Bioinformatics Advances. 4(1). vbae035–vbae035. 1 indexed citations
3.
Chang, Jessie J.‐Y., Samantha L. Grimley, Georgia Deliyannis, et al.. (2024). Uncovering strain- and age-dependent innate immune responses to SARS-CoV-2 infection in air-liquid-interface cultured nasal epithelia. iScience. 27(6). 110009–110009. 1 indexed citations
4.
Li, Fuyi, Yue Bi, Miranda E. Pitt, et al.. (2023). Digerati – A multipath parallel hybrid deep learning framework for the identification of mycobacterial PE/PPE proteins. Computers in Biology and Medicine. 163. 107155–107155. 11 indexed citations
5.
Chang, Jessie J.‐Y., Ricardo De Paoli‐Iseppi, Chenxi Zhou, et al.. (2022). Long-Read RNA Sequencing Identifies Polyadenylation Elongation and Differential Transcript Usage of Host Transcripts During SARS-CoV-2 In Vitro Infection. Frontiers in Immunology. 13. 832223–832223. 12 indexed citations
6.
Li, Fuyi, Xudong Guo, Dongxu Xiang, et al.. (2022). Computational analysis and prediction of PE_PGRS proteins using machine learning. Computational and Structural Biotechnology Journal. 20. 662–674. 22 indexed citations
7.
Chang, Jessie J.‐Y., Miranda E. Pitt, George Taiaroa, et al.. (2021). Transcriptional and epi-transcriptional dynamics of SARS-CoV-2 during cellular infection. Cell Reports. 35(6). 109108–109108. 24 indexed citations
8.
Pitt, Miranda E., Son Hoang Nguyen, Tânia Duarte, et al.. (2020). Evaluating the genome and resistome of extensively drug-resistant Klebsiella pneumoniae using native DNA and RNA Nanopore sequencing. GigaScience. 9(2). 25 indexed citations
9.
Pitt, Miranda E., Son Hoang Nguyen, Tânia Duarte, et al.. (2020). Complete Genome Sequences of Clinical Pandoraea fibrosis Isolates. Microbiology Resource Announcements. 9(13). 1 indexed citations
10.
Bialasiewicz, Seweryn, Tânia Duarte, Son Hoang Nguyen, et al.. (2019). Rapid diagnosis of Capnocytophaga canimorsus septic shock in an immunocompetent individual using real-time Nanopore sequencing: a case report. BMC Infectious Diseases. 19(1). 660–660. 17 indexed citations
11.
Pitt, Miranda E., Alysha G. Elliott, Minh Duc Cao, et al.. (2018). Multifactorial chromosomal variants regulate polymyxin resistance in extensively drug-resistant Klebsiella pneumoniae. Microbial Genomics. 4(3). 54 indexed citations
12.
Pitt, Miranda E., Minh Duc Cao, Mark S. Butler, et al.. (2018). Octapeptin C4 and polymyxin resistance occur via distinct pathways in an epidemic XDR Klebsiella pneumoniae ST258 isolate. Journal of Antimicrobial Chemotherapy. 74(3). 582–593. 14 indexed citations
13.
Blaskovich, Mark A. T., Miranda E. Pitt, Alysha G. Elliott, & Matthew A. Cooper. (2018). Can octapeptin antibiotics combat extensively drug-resistant (XDR) bacteria?. Expert Review of Anti-infective Therapy. 16(6). 485–499. 15 indexed citations
14.
Tseng, Hsu‐Wen, Miranda E. Pitt, Tibor T. Glant, et al.. (2016). Inflammation-driven bone formation in a mouse model of ankylosing spondylitis: sequential not parallel processes. Arthritis Research & Therapy. 18(1). 35–35. 35 indexed citations
15.
Phetsang, Wanida, Ruby Pelingon, Mark S. Butler, et al.. (2016). Fluorescent Trimethoprim Conjugate Probes To Assess Drug Accumulation in Wild Type and Mutant Escherichia coli. ACS Infectious Diseases. 2(10). 688–701. 45 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026